LMAN2
Vesicular integral-membrane protein VIP36
Also known as: C5orf8, GP36B, LMAN2_HUMAN, VIP36
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12907
- Gene
- LMAN2
- Ensembl
- ENSG00000169223
- Chromosome
- 5
- Canonical length
- 356 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
This gene encodes a type I transmembrane lectin that shuttles between the endoplasmic reticulum, the Golgi apparatus and the plasma membrane. The encoded protein binds high mannose type glycoproteins and may facilitate their sorting, trafficking and quality control. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
356 residues, UniProt reviewed canonical sequence.
>Q12907|LMAN2
1 MAAEGWIWRW GWGRRCLGRP GLLGPGPGPT TPLFLLLLLG SVTADITDGN SEHLKREHSL
61 IKPYQGVGSS SMPLWDFQGS TMLTSQYVRL TPDERSKEGS IWNHQPCFLK DWEMHVHFKV
121 HGTGKKNLHG DGIALWYTRD RLVPGPVFGS KDNFHGLAIF LDTYPNDETT ERVFPYISVM
181 VNNGSLSYDH SKDGRWTELA GCTADFRNRD HDTFLAVRYS RGRLTVMTDL EDKNEWKNCI
241 DITGVRLPTG YYFGASAGTG DLSDNHDIIS MKLFQLMVEH TPDEESIDWT KIEPSVNFLK
301 SPKDNVDDPT GNFRSGPLTG WRVFLLLLCA LLGIVVCAVV GAVVFQKRQE RNKRFYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LMAN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 213 nTPM
Expression across tissuesHPA
Tissue
- liver: 213 nTPM
- pancreas: 161 nTPM
- esophagus: 152 nTPM
- epididymis: 122 nTPM
- choroid plexus: 115 nTPM
- salivary gland: 107 nTPM
Single-cell type
- syncytiotrophoblasts: 698 nCPM
- extravillous trophoblasts: 615 nCPM
- esophageal suprabasal cells: 594 nCPM
- epididymal principal cells: 570 nCPM
- esophageal apical cells: 568 nCPM
- esophageal basal cells: 438 nCPM
Immune cell
- total PBMC: 825 nTPM
- basophil: 562 nTPM
- neutrophil: 549 nTPM
- plasmacytoid DC: 499 nTPM
- eosinophil: 476 nTPM
- classical monocyte: 410 nTPM
Brain region
- choroid plexus: 78 nTPM
- thalamus: 46 nTPM
- medulla oblongata: 43 nTPM
- hypothalamus: 40 nTPM
- hippocampal formation: 39 nTPM
- white matter: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.38
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum to Golgi vesicle-mediated transport
- positive regulation of phagocytosis
- protein transport
- retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LMAN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LMAN2 as an antibody target. Whether an autoantibody or antibody against LMAN2 could matter depends on whether native LMAN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LMAN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LMAN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...